Efficacy and Safety of Dasiglucagon for Treatment of Post-bariatric Hypoglycemia in Roux-en-Y Gastric Bypass (RYGB) Operated Adults

NCT04824872 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Never started

Conditions

Hypoglycemia
Glucose Metabolism Disorders

Interventions

DRUG: Dasiglucagon
DRUG: Dasiglucagon
DRUG: Placebo

Sponsor

Zealand Pharma